Understanding lung endothelial barrier integrity in sepsis
Official title: Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
Run by Mater Dei Hospital, Malta · NCT06287684 · Data updated 2026-11-12
This study is trying to find out how the lungs are affected in people with sepsis to see if certain blood markers can help predict their recovery and guide better treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 460 (estimated) |
| Sponsor | Mater Dei Hospital, Malta Academic / other |
| Locations | 1 site (Msida) |
| Status | Recruiting |
| Started | September 13, 2023 |
| Main results expected | December 30, 2028 |
| Study ends | December 30, 2028 |
| Registry record updated | July 16, 2025 |
| Trial ID | NCT06287684 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with acute respiratory tract infections due to pneumonia.
✕Probably not a fit
Patients who are pregnant, prisoners, or have conditions like aspiration pneumonitis or ventilator-associated pneumonia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the dynamics of lung endothelial barrier integrity in patients with sepsis, septic shock, and pneumonia. It aims to classify sepsis patients into molecular endotypes to better understand their prognosis and response to treatment. By utilizing blood transcriptomics and bronchoalveolar lavage protein profiling, the study seeks to identify specific biomarkers associated with poor outcomes in sepsis. The findings could help tailor therapeutic interventions based on individual patient profiles.
Why it matters
Potential benefit: If successful, this study could lead to more personalized treatment strategies for sepsis patients, improving their outcomes.
How similar studies have gone: While the approach of classifying sepsis patients into molecular endotypes is gaining traction, this specific study's methodology is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Age ≥ 18 years * Consent card signed Exclusion criteria: * Consent card not signed * Pregnancy * Prisoners * Elective cardiac surgery patients with an uncomplicated stay.
Where it's running
-
Mater Dei hospital, Intensive Therapy Unit
Msida, Malta Recruiting
Study contacts
- Study coordinator: Brendon P. Scicluna, Ph.D.
- Email: brendon.scicluna@um.edu.mt
- Phone: +35623403869
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
-
Personalized Fluid Resuscitation in the Emergency Department
This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.
-
Discordance between capillary refill time and oxygen use in septic shock
This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.
-
Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock
This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.
-
Cortisol Levels and Mortality in Septic Shock ICU Patients
This study tests whether cortisol levels can predict death or recovery in adults with sepsis or septic shock in the ICU.
-
oXiris hemofilter use for adults with septic shock and kidney failure
This study tests whether using the oXiris hemofilter during continuous dialysis helps adults with septic shock and acute kidney injury survive and stabilize faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.